LEX Diagnostics
Gabriela Sandoval-Plata is a skilled PCR Development Scientist at LEX Diagnostics since October 2022, specializing in the development of diagnostic systems for human pathogens. Gabriela has extensive research and development experience from previous roles at Laboratorios Silanes S.A. de C.V., including a Chemist in Technology, where project management for CONACYT-funded projects was undertaken, focusing on lateral flow tests and molecular testing methods like RT-PCR and pyrosequencing. Gabriela also completed internships involving gene expression quantitation and the identification of clinically relevant fungi. Academically, Gabriela holds a PhD in Academic Rheumatology and a Master of Science in Molecular Genetics and Diagnostics from the University of Nottingham, in addition to a Biotechnology Engineering degree from Tecnológico de Monterrey.
LEX Diagnostics
LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care. Having solved the PCR cost problem, LEX focuses tightly on nasal and oral samples, and on viral pathogens, to avoid the other high-cost elements of traditional molecular diagnostic products. LEX Diagnostics is a spin-out from TTP plc, atechnology development company in the life science and medical device sector. The origins of the LEX technology lie in an internal R&D project to reduce the time it takes to get a result from a PCR test. It formed a company when it became clear the solution also reduced the cost and size of any diagnostic device using it.LEX Diagnostics was founded in 2020 and is based in Melbourn, United Kingdom.